Retatrutide 20 mg – GLP-1 – Fat-Burning Peptide
Retatrutide 20 mg is a next-generation peptide based on triple receptor agonism (GLP-1, GIP, and glucagon). It is designed to maximize appetite control, accelerate basal energy expenditure, and promote fat loss while preserving lean body mass. Supplied in a high-purity lyophilized vial for reconstitution, with a guarantee of authenticity from FIG Farma and Driada.
If you want a lower strength: Retatrutide 10 mg
- Shipping (if the product is in stock): 3 business days for processing and 5 to 20 business days for shipping
- Processing and shipping costs: €27 throughout Italy
What is Retatrutide 20 mg?
Retatrutide 20 mg represents the most advanced development in the class of peptides for weight management, targeted weight loss, and body composition. Unlike treatments from previous generations, Retatrutide acts as a triple receptor agonist, selectively stimulating three key metabolic hormones: GLP-1, GIP, and glucagon.
The 20 mg freeze-dried powder formulation is designed to ensure more convenient and cost-effective management of medium- and long-term treatment cycles, reducing the need for frequent reorders and offering ideal dosing flexibility for both initial treatment phases and more advanced protocols.
If you'd like a different strength: Retatrutide 10 mg
Why Retatrutide 20 mg outperforms traditional GLP-1s
While traditional compounds (such asSemaglutide/Ozempic) act solely on the GLP-1 receptor and dual agonists (such as Tirzepatide/Mounjaro) combine GLP-1 and GIP, Retatrutide 20 mg introduces the key component of glucagon.
This mechanism offers tangible benefits:
-
Active increase in caloric expenditure: It does more than just suppress hunger; it also increases resting energy expenditure through thermogenesis and fat oxidation.
-
Less loss of lean body mass: By increasing energy expenditure from fat, it better protects muscle tissue than a calorie deficit induced solely by appetite suppressants.
-
More stable energy levels: It reduces the typical feeling of lethargy or fatigue often associated with strict low-calorie diets.
-
Optimal blood sugar management: Improves insulin sensitivity and eliminates post-meal blood sugar spikes, preventing emotional eating.
Mechanism of Action: Triple Agonism
The metabolic efficacy of Retatrutide 20 mg stems from the synergy of three distinct biological pathways:
-
GLP-1 (Glucagon-Like Peptide-1): It slows gastric emptying, prolongs the feeling of fullness in the brain, and reduces daily calorie intake.
-
GIP (Glucose-Dependent Insulinotropic Polypeptide): Optimizes glucose-dependent insulin secretion, improves carbohydrate tolerance, and promotes proper nutrient distribution.
-
Glucagon: It directly stimulates lipolysis in brown and white adipose tissue, increasing the basal metabolic rate and accelerating thermogenesis.
Key Benefits and Results
-
Significant reduction in visceral and subcutaneous fat: The combined effect of calorie restriction and increased energy expenditure.
-
Precision muscle definition: Particularly valued in advanced fitness and bodybuilding for achieving low body fat percentages without losing muscle mass.
-
Craving Control: A drastic reduction in cravings for sugar and high-calorie foods.
-
Better adherence to the diet: It allows you to maintain low-calorie diets over the long term with minimal physical and mental stress.
Form, Reconstitution, and Dosage of Retatrutide 20 mg
The product comes in a 20-mg vacuum-sealed vial of freeze-dried powder, ensuring maximum stability of the molecule until the time of use.
How to Reconstitute the 20-mg Vial
-
Use bacteriostaticwater (BAC water) for mixing (1 to 2 ml of diluent is recommended, depending on the desired concentration).
-
Slowly pour the liquid down the inner wall of the vial, taking care not to spray it directly onto the powder so as not to damage the peptide structure.
-
Gently roll the vial between your fingers until it is completely dissolved. Do not shake vigorously.
Recommended Administration Protocol
The medication is administered by subcutaneous injection (into the abdomen, thigh, or buttock), generally once a week at the same time:
-
Titration phase (Weeks 1–4): 0.5 mg – 1 mg per week to assess individual tolerance.
-
Maintenance/Progression Phase: 2 mg–4 mg per week, depending on metabolic response and goals.
-
Advanced stages (for experienced athletes only): Gradual increases based on individual needs.
Guidelines for Use and Tolerability
Retatrutide has a generally favorable tolerability profile. Mild, transient gastrointestinal symptoms may occur in the early stages:
-
Mild nausea (especially in the first few days after the injection).
-
Early feeling of fullness.
-
Mild disturbance of bowel function.
Practical tips: Stay adequately hydrated throughout the day, spread your protein intake across small, regular meals, and avoid foods that are too high in fat for 24 hours after the injection.
Storage
-
Before reconstitution: Store the unopened vial in the refrigerator at 2°C to 8°C, protected from direct light and heat sources.
-
After reconstitution: Store strictly in the refrigerator (2°C – 8°C). Do not freeze. Use within 30–40 days after mixing with bacteriostatic water.
FIG Farma & Driada Quality Assurance
Every batch of Retatrutide 20 mg distributed by FIG Farma in collaboration with Driada undergoes rigorous laboratory testing (HPLC and mass spectrometry) to verify purity of over 99% and actual strength. Original Driada packaging includes anti-counterfeiting verification systems with a unique code that can be verified on the official website.










